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Mitochondrial dysfunction following traumatic brain and spinal cord injury (TBI and SCI)
plays a pivotal role in the development of secondary pathophysiology and subsequent
neuronal cell death. Previously, we demonstrated a loss of mitochondrial bioenergetics
in the first 24 h following TBI and SCI initiates a rapid and extensive necrotic event
at the primary site of injury. Within the mitochondrial derived mechanisms, the cross
talk and imbalance amongst the processes of excitotoxicity, Ca2+ cycling/overload, ATP
synthesis, free radical production and oxidative damage ultimately lead to mitochondrial
damage followed by neuronal cell death. Mitochondria are one of the important
organelles that regulate intracellular calcium (Ca2+) homeostasis and are equipped with
a tightly regulated Ca2+ transport system. However, owing to the lack of consensus
and the link between downstream effects of calcium in published literature, we
undertook a systematic in vitro study for measuring concentration dependent effects
of calcium (100–1000nmols/mg mitochondrial protein) on mitochondrial respiration,
enzyme activities, reactive oxygen/nitrogen species (ROS/RNS) generation, membrane
potential () and oxidative damage markers in isolated brain mitochondria. We
observed a dose- and time-dependent inhibition of mitochondrial respiration by calcium
without influencing mitochondrial pyruvate dehydrogenase complex (PDHC) and NADH
dehydrogenase (Complex I) enzyme activities. We observed dose-dependent decreased
production of hydrogen peroxide and total ROS/RNS species generation by calcium and
no significant changes in protein and lipid oxidative damage markers. These results may
shed new light on the prevailing dogma of the direct effects of calcium on mitochondrial
bioenergetics, free radical production and oxidative stress parameters that are primary
regulatory mitochondrial mechanisms following neuronal injury.
Keywords: brain mitochondria, calcium, mitochondrial bioenergetics, enzyme activities, membrane permeability
transition (mPT), membrane potential (), reactive oxygen species (ROS), oxidative damage
INTRODUCTION
Mitochondria act as a biological switch in determining a cell’s
fate. They provide the necessary energy for cell life and in cases
of noxious stimuli cause cell death by necrosis and/or apopto-
sis. The physiological function of mitochondria is to produce
adenosine triphosphate (ATP), the energy currency of the cell,
through Krebs cycle and electron transport chain (ETC) activ-
ity. This ATP is utilized for various biological reactions inside the
cell. Mitochondria are also involved in calcium (Ca2+) home-
ostasis. However, during ATP production, mitochondria also
produce reactive oxygen/nitrogen species (ROS/RNS) as a by-
product, mainly in the form of superoxide. Mitochondria are
also equipped with anti-oxidant molecules and enzymes, and
repair mechanisms. However, during pathophysiological condi-
tions such as neurodegeneration and/or neurotrauma, the bal-
ance between ROS and anti-oxidants is tipped causing oxidative
stress and Ca2+ dysregulation. This leads to mitochondrial dys-
function, triggering a signaling cascade resulting ultimately in cell
death (Pedersen, 1999; Duchen, 2000; Kroemer and Reed, 2000;
Newmeyer and Ferguson-Miller, 2003; Smaili et al., 2003; Sullivan
et al., 2005; Wallace, 2005; Geddes and Sullivan, 2009).
The brain is a unique organ as it consists of a heterogeneous
composition of cell types (neurons and glial cells) with distinct
structural (cortex, hippocampus, striatum etc.) regions and func-
tional (motor vs. sensory vs. memory) areas. It has low levels of
stored glycogen; almost exclusively utilizes glucose as its energy
source under normal conditions and consumes about 20% of
total body oxygen even though it constitutes only 2% of total body
mass. In addition, it contains high amounts of unsaturated fatty
acids along with a high iron content, and has been found to be
low in antioxidant defenses making it a prime target for oxidative
stress (Floyd and Hensley, 2002).
Calcium homeostasis is critical for cell survival, human health
and diseases (Berridge et al., 2000; Sullivan et al., 2005; Geddes
and Sullivan, 2009; Nicholls, 2009; Pivovarova and Andrews,
2010). Levels of Ca2+ are maintained in the cytoplasm at a resting
level of about 100 nM, and can rise up to 1μM upon activation,
as opposed to an extracellular concentration of approximately
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1.2mM (Berridge et al., 2000). In contrast, the mitochondrial
concentration of Ca2+ responds to increases in the cytoplasmic
concentrations such that the mitochondrial load is 10,000 fold
higher due to the electrogenic, membrane potential driven uptake
via the Ca2+uniporter. Calcium exhibits wide-ranging spatial and
temporal dynamics resulting in an extensive, but highly regulated,
Ca2+ signaling network (Carafoli et al., 2001). At any given time,
intracellular Ca2+ levels are maintained by a balance of “on” reac-
tions enabling Ca2+ to enter the cell and “off” reactions resulting
in its extrusion from the intracellular space, and the variations
of on/off reactions generate Ca2+ transients. The “on” reactions
are activated primarily by the flow of Ca2+, down its concen-
tration gradient from the extracellular space, upon membrane
depolarization via voltage-operated channels (VOC that include
L-, P/Q-, N-, R-, and T-type channels) or agonist binding (gluta-
mate, ATP, acetylcholine) via receptor-operated channels [ROC;
ex: N-methyl-D-aspartate (NMDA) receptors] or store-operated
channels (SOC) on the plasma membrane (PM). This initiates
a signaling cascade engaging G-protein linked receptors, recep-
tor tyrosine kinases (TyrK), and Phospholipase C (PLC). In a
calcium-induced manner, Ca2+ can be released from internal
stores such as endoplasmic reticulum (ER) predominantly via
Ca2+-sensitive inositol 1,4,5-trisphosphate receptors (InsP3R) or
ryanodine receptors (RyR) (Michelangeli et al., 2005).
Calcium is taken up by the mitochondria through a uniporter
when the cytoplasmic Ca2+ level reaches around 1μM and it
is released when levels decrease below (Chalmers and Nicholls,
2003; Nicholls, 2005). Calcium is shown to regulate the citric acid
cycle (TCA or Krebs cycle) by activating NAD+-dependent pyru-
vate dehydrogenase complex (PDHC), isocitrate dehydrogenase
(ICDH) and α-ketoglutarate dehydrogenase complex (KGDHC)
resulting in increases of NADH levels (Denton et al., 1988; Wan
et al., 1989) as well as ATP production by activating the ATP syn-
thase (Territo et al., 2000). The slow release of Ca2+ that occurs
also regulates LTP and LTD by maintaining higher than nor-
mal levels in the cytoplasm. These reactions that occur within
the mitochondria that relate to bioenergetics take place in the
0.1 to 1μM concentration range with fast kinetics on the order
of milli-seconds and may provide a physiological relevance. It is
hypothesized that calcium inside the mitochondrial matrix forms
a Ca2+-phosphate compound that is readily dissociable, which
keeps free matrix Ca2+ at low levels. At still higher concentrations
(>1μM), calcium could inhibit respiration, cause mitochondria
to undergo mPT and release pro-apoptotic proteins leading to
cell death (Gunter et al., 2004; Nicholls and Chalmers, 2004;
Jemmerson et al., 2005).
Several lines of evidence suggest that perturbations in intracel-
lular Ca2+ homeostasis are involved in mitochondrial mediated
cell death. Previously, our laboratory has demonstrated a loss of
mitochondrial bioenergetics in the first 24 h following traumatic
brain and spinal cord injury (TBI and SCI). Thus, mitochondria
play a pivotal role in the development of secondary pathophysiol-
ogy and subsequent neuronal cell death. However, the sequence of
events leading from mitochondrial Ca2+ overload to ROS medi-
ated damage in the mitochondria are still unclear. In light of
these findings and gaps therein, we measured the direct effects
of calcium concentrations on mitochondrial respiration, enzyme
activity, free radical generation and oxidative damage markers in
isolated brain mitochondria. The current data may shed light on
the disparity of results in the literature concerning the effects of
Ca2+ on mitochondrial function and ROS production. Further,
it may be helpful in designing novel therapeutic strategies on
the basis of current research findings on mitochondrial dys-
function parameters as they are common pathologies following




Mannitol, sucrose, bovine serum albumin (BSA), ethylene glycol-
bis(2-aminoethylether)-N,N,N′,N′-tetraacetic acid (EGTA),
hydroxyethyl piperazine-1-ethanesulfonic acid potassium
salt (HEPES), potassium phosphate monobasic anhydrous
(KH2PO4), magnesium chloride (MgCl2), malate, pyru-
vate, adenosine 5′-diphosphate (ADP), succinate, calcium
chloride (CaCl2), L-Arginine (L-Arg), potassium chloride
(KCl), and horseradish peroxidase (HRP) were purchased
from Sigma-Aldrich (St. Louis, MO, USA). Dihydro dichlo-
rofluorescin diacetate (H2DCF-DA), tetramethylrhodamine
ethyl ester (TMRE) were purchased from Molecular Probes
(Eugene, OR). oligomycin A, rotenone and carbonyl cyanide
4-(trifluoromethoxy) phenylhydrazone (FCCP) were purchased
from Biomol (Plymouth Meeting, PA). Bicinchoninic acid (BCA)
protein assay kit was purchased from Pierce (Rockford, IL).
CALCIUM CONCENTRATIONS
Stocks (5mM CaCl2 solution) were prepared fresh daily in
distilled water followed by serial dilution i.e., 100, 200, 500,
and 1000, 20,000 nmol/mg in respiration buffer before experi-
ment. The final calcium concentrations i.e., 100, 200, 500, and
1000, 20,000 nmol/mg mitochondrial protein were alternatively
expressed as 10, 20, 50, and 100, 2000μM respectively.
ISOLATION AND PURIFICATION OF BRAIN MITOCHONDRIA
All experimental protocols involving animals were approved by
the University of Kentucky Animal Use and Care Committee. This
protocol contains modifications of previously described proce-
dures (Brown et al., 2004; Nukala et al., 2006). All procedures
were performed on ice throughout the protocol. Male Sprague-
Dawley rats (∼250–300 g) were decapitated and the brains were
rapidly removed. The cortices were dissected out and placed in
an all-glass dounce homogenizer containing five times the vol-
ume of isolation buffer with 1mM EGTA (215mM mannitol,
75mM sucrose, 0.1% BSA, 20mM HEPES, 1mM EGTA, and
pH is adjusted to 7.2 with KOH). The tissue was homogenized
and mitochondria were isolated by differential centrifugation.
The homogenate was centrifuged twice at 1300 × g for 3min
in an eppendorf micro-centrifuge at 4◦C. The resulting super-
natant was transferred and topped off with isolation buffer with
EGTA and centrifuged at 13,000 × g for 10min. The super-
natant was discarded and the pellet was resuspended in 500μL
of isolation buffer with EGTA. The trapped mitochondria were
released from synaptosomes after synaptosomal membranes were
disrupted using a nitrogen cell bomb incubated at 1200 psi for
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10min to obtain maximal yield of total (synaptic and non-
synaptic) mitochondria. The mitochondrial sample was further
purified by percoll density gradient centrifugation. Stocks of 40,
24, and 30% percoll were prepared fresh in isolation buffer with
EGTA. 3.5ml of 24% stock was carefully layered over 3.5ml of
40% in 13ml ultraclear tubes. Equal volumes of 30% percoll was
added to the sample to get a 4ml of 15% final concentration and
loaded gently on top of the 24% layer. The sample was centrifuged
in fixed angle type SE-12 rotor at 30,400 × g for 10min at 4◦C
in RC 5C Plus (Sorvall) high-speed centrifuge. Fraction 3, con-
taining total mitochondria, formed at the interphase of 40 and
24% layers and was carefully removed and placed in fresh tubes.
The tubes were topped off with isolation buffer without EGTA
(215mM mannitol, 75mM sucrose, 0.1% BSA, 20mM HEPES
and pH is adjusted to 7.2 with KOH) and centrifuged in fixed
angle SE-12 rotor at 16,700 × g for 15min at 4◦C in RC 5C Plus
(Sorvall) high-speed centrifuge. The supernatants were carefully
removed and the tubes were topped off with isolation buffer with-
out EGTA and centrifuged again at 13,000 × g for 10min at 4◦C.
The supernatants were carefully removed and the loose pellets at
the bottom were transferred to microcentrifuge tubes. The tubes
were topped off with isolation buffer without EGTA and cen-
trifuged at 13,000 × g for 10min at 4◦C. The supernatants were
carefully removed and the pellets were resuspended in 500μL of
isolation buffer without EGTA. The tubes were topped off with
isolation buffer without EGTA and centrifuged at 10,000 × g
for 5min at 4◦C to yield a tighter pellet. The final mitochon-
drial pellet was resuspended in isolation buffer without EGTA
to yield a concentration of ∼10mg/ml. The protein concentra-
tion was determined using the BCA protein assay kit measuring
absorbance at 562 nm with a BioTek Synergy HT plate reader
(Winooski, Vermont).
ELECTRON MICROSCOPY
After the last centrifugation, some of the mitochondrial pel-
lets were fixed in 4% glutaraldehyde overnight at 4◦C before
being embedded for electron microscopy. Next, the pellets were
washed overnight at 4◦C in 0.1M sodiumcacodylate buffer, fol-
lowed by 1 h secondary fixation at room temperature in 1%
osmium tetroxide. Then, the mitochondrial pellets were rinsed
with distilled water and dehydrated for 10min each in 70, 85,
95%, twice in 100% ethanol and twice in propylene oxide. The
pellets were placed in a 1:1 mixture of propylene oxide and
Epon/Araldite resin and infiltrated overnight on a rotator. Next,
100% Epon/Araldite resin was added and rotated for 1 h at room
temperature. Finally fresh resin was prepared and degassed using
a vacuum chamber. The mitochondrial pellets were added to
the flat molds, filled with fresh resin, and baked overnight at
60◦C. The 90 nm sections were cut using an RMCMT-7000 ultra-
microtome mounted on 150 mesh copper grids and stained with
uranyl acetate and lead citrate. The sections were examined using
a Zeiss 902 electron microscope (Pandya et al., 2009).
WESTERN BLOTTING
Western blots for COX and VDAC were carried out as described
previously (Brown et al., 2004; Nukala et al., 2006). Briefly,
the various samples were diluted to 1μg/μl in isolation buffer
without EGTA and used for western blots. Sample buffer was
added to the samples based on relative protein concentrations
and boiled for 10min. Samples (5–20μg each) were separated by
SDS-PAGE 3–8% Tris-acetate gels (NuPage), along with molecu-
lar weight markers (Multi-Marker, Invitrogen). Following SDS-
PAGE, polypeptides were transferred electrophoretically onto
0.2μm nitrocellulose membranes. Membranes were incubated
at room temperature for 1–2 h in 5% non-fat milk in 50mM
Tris-saline containing 0.05% Tween-20 at pH 7.5 (TTBS). The
blots were incubated overnight in the primary antibody in TTBS
at room temperature. The primary antibodies used in study
included monoclonal cytochrome c oxidase subunit IV (COX
IV) at 1:20,000 from Molecular Probes (Eugene, OR, USA) and
polyclonal voltage-dependent anion channel (VDAC) at 1:10,000
from Affinity Bioreagents. After overnight incubation in pri-
mary antibody, the membranes were rinsed three times in TTBS
and incubated in secondary antibody for 1–2 hin either HRP-
conjugated goat anti-mouse IgG (1:6000) for COX-IV, or HRP-
conjugated goat anti-rabbit IgG (1:6000) for VDAC. The blots
were rinsed thoroughly in TTBS and were developed using Pierce
SuperSignal West Pico chemi-luminescent substrate and analyzed
using Kodak Image-Station.
RESPIRATION STUDIES
The respiratory activity of isolated mitochondria was measured
using a Clark-type oxygen electrode (Hansatech Instruments,
Norfolk, England) (Brown et al., 2004; Nukala et al., 2006)
in the presence of different concentrations of calcium (0, 100,
200, 500, 1000 nmol/mg mitochondrial protein). Approximately
120–160μg/mL of isolated mitochondria were suspended in a
sealed, constantly stirred, and thermostatically-controlled cham-
ber at 37◦C in respiration buffer (125mM KCl, 2mM MgCl2,
2.5mM KH2PO4, 0.1% BSA, 20mM HEPES at pH 7.2). The rate
of oxygen consumption was calculated based on the slope of the
response of isolated mitochondria to oxidative substrates in the
order- 5mM pyruvate and 2.5mM malate; 150μM ADP; 2μM
of oligomycin; 2μM FCCP; 1μM rotenone and 10mM succinate
(Pandya et al., 2007, 2009, 2011; Patel et al., 2009).
MITOCHONDRIAL ENZYME ACTIVITIES
For measurement of PDHC and Complex I enzyme activities,
mitochondrial protein samples (10μg/100μl) were co-incubated
with increasing calcium concentrations (0–1000 nmols/mg mito-
chondrial protein) range. Additionally, a higher calcium dose
(20000 nmol/mg mitochondrial protein) was also co-incubated
to verify calcium effects at extremely high concentrations.
Complex I enzyme activity was determined by measuring the
decrease in NADH fluorescence at 460 nm in the presence and
absence of rotenone, as previously described (Sriram et al.,
1998; Sullivan et al., 2004; Gash et al., 2008). 10μg of mito-
chondrial protein was added to 25mM KPO4 pH 7.2, 5mM
MgCl2, 1mM KCN, 1mg/ml BSA, and 150μM NADH. Either
1μl of 1mM rotenone or 1μl of 25mM KPO4 was added
so that with and without rotenone samples were compared.
The reaction was started by the addition of 50μM of coen-
zyme Q1. Enzyme activity was calculated by subtracting the
change in NADH emission in the absence of rotenone from
the change in NADH emission in the presence of rotenone
at 30◦C using 96-well plate BioTek Synergy HT plate reader
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(BioTek, Winooski, VT). Similarly, PDHC activity was measured
as previously described using a BioTek Synergy HT plate reader
(Winooski, VT, USA) (Starkov et al., 2004). 10μg of mitochon-
drial protein were added into the buffer containing 50mM KCl,
10mM HEPES pH 7.4, 0.3mM thiamine pyrophosphate (TPP),
10μM CaCl2,0.2mM MgCl2, 5mM pyruvate, 1μM rotenone,
and 0.2mM NAD+. The reaction was started by the addition of
0.14mMCoASH and increased NAD+ fluorescence was recorded
for 1min intervals at 30◦C. The PDHC activity was calculated
and expressed as percentage change as compared to control
group.
FLUORESCENT SPECTROMETRY TO MEASURE MITOCHONDRIAL TOTAL
ROS/RNS GENERATION AND MEMBRANE POTENTIAL ()
Mitochondrial ROS/RNS levels and membrane potential were
measured using a Shimadzu spectrofluorophotometer (RF-5301)
as described previously (Brown et al., 2006; Pandya et al., 2011).
Mitochondrial protein (100μg) was added to a thermostatically
controlled (37◦C), constantly stirred cuvette in a total volume
of 2ml of 125mM KCl buffer, containing 5mM pyruvate and
2.5mM malate, 150μM ADP, 2μM of oligomycin, 1mM L-Arg,
10μM H2DCF-DA (Ex: 485 nm, Em: 530 nm), 150 nM TMRE
(Ex: 550 nm, Em: 575 nm) and 25U/ml HRP. Each run was per-
formed following a baseline reading of the buffer. Mitochondria,
calcium and the substrates/inhibitors were added as indicated.
The slope of DCF fluorescence was quantified for the respective
conditions including baseline and expressed in arbitrary units.
Alternately, for an additional confirmation of ROS generation,
we measured mitochondrial H2O2 and total ROS/RNS produc-
tion using 1μM Amplex Red (Ex: 530 nm, Em: 590 nm) and
10μM H2DCF-DA (Ex: 485 nm, Em: 530 nm) in the Biotek
Synergy HT 96 well plate reader as previously described (Chen
et al., 2003; Pandya et al., 2007, 2011; Visavadiya et al., 2013).
Isolated mitochondria (10μg) were added to 100μl of 125mM
KCl respiration buffer with 5mM pyruvate and 2.5mMmalate as
oxidative substrates and incubated at 37◦C. Fluorescence of the
oxidized probe was measured every minute over a 10min period
(H2O2 production) and rate of total ROS/RNS production was
calculated as the rate of Amplex Red fluorescence increase over
15–30min incubation. Background control values (reagent and
mitochondrial blanks) were subtracted from the results to get the
slope for each experiment as calculated and expressed in arbitrary
fluorescence units.
SLOT-BLOTS FOR OXIDATIVE MARKERS
Samples used for respiration were centrifuged at 10,000 g for
5min. Buffer containing 0.1M PBS and protease inhibitor cock-
tail (Roche) was added to samples, then diluted to 200 ng/ml with
the protease inhibitor cocktail in 0.1M PBS. For oxidative dam-
age determination, the OxyBlot Protein Oxidation Detection Kit
(Chemicon) was used according to manufacturer’s specifications.
Samples were loaded at 1 ug/well onto the slot blot appara-
tus and transferred onto 0.2μm thick nitrocellulose membrane
under vacuum. The membranes were blocked for 2 h, with agita-
tion, in 1% Casein/PBS at room temperature. Primary antibodies
were diluted in 0.1% casein/PBST and used as follows—rabbit-α-
DNP (Chemicon) at 1:1000, mouse-α-3NT (Upstate) at 1:2000,
rabbit-α-HNE (Calbiochem) at 1:10,000. Blots were incubated in
primary antibody overnight, with agitation, at 4◦C. Blots were
rinsed with PBST and incubated Goat-α-Mouse (Jackson, for
3-NT) and Goat-α-Rabbit (Upstate; for HNE & DNP) for 2 h,
with agitation, at room temperature. Blots were rinsed with PBST,
dried, scanned, and quantified using a Bio-Rad scanner (Patel
et al., 2009).
STATISTICAL ANALYSIS
All results are expressed as means ± s.e.m. For statistical evalua-
tion, One-way analysis of variance (ANOVA) was used to test for
differences involving multiple experimental groups or Student’s
t-test was employed for data analysis involving only two groups.
When required, Fisher’s post-hoc test was used for pair-wise com-
parisons among multiple groups. Significance was set at p < 0.05
for all analyses.
RESULTS
CHARACTERIZATION OF MITOCHONDRIAL PREPARATIONS
We initially characterized our mitochondrial isolation and
purification methodologies by analyzing the ultra-structure of
mitochondria and probing for mitochondrial markers. The
electron-microscopy pictures indicate that the preparations pre-
dominantly contain mitochondria (Figure 1A). Mitochondria
subjected to the percoll-purification method maintained their
structures, including intact outer and inner mitochondrial mem-
branes as well as tight cristae (Figures 1B,C). Mitochondrial
marker proteins (VDAC and COX) were probed by western blots
in the various fractions obtained during the sequential purifica-
tion steps (Figure 2). We observed an enrichment of both outer
(VDAC) and inner (COX)membranemarkers in the percoll puri-
fied fraction whereas they are markedly lower in the sequential
fractions collected during the preparation.
CALCIUM AND MITOCHONDRIAL RESPIRATION
To determine the possible effects of Ca2+ on mitochondrial func-
tion, we measured mitochondrial oxygen consumption using
a Clark-type electrode and observed a Ca2+-mediated, signif-
icant reduction of mitochondrial respiration (Figure 3). The
reduction in respiratory control ratio (RCR; State III/State IV)
was dose-dependent (Figure 4). We then analyzed each of the
substrate/inhibitor induced respiration states (Figure 5). We
observed that Complex I (pyruvate/malate as substrates), NADH-
linked respiration was affected specifically by calcium in a dose-
dependent manner. We observed higher oxygen consumption
upon addition of calcium accompanied by a reduction in State
III respiration (in presence of ADP). However, State IV respi-
ration (in presence of oligomycin- Complex V inhibitor) was
not affected, indicating that the concentrations of Ca2+ utilized
were below the levels to initiate mPT. There was also a trend of
reduction in maximal oxygen consumption upon addition of the
uncoupler FCCP. There were no changes observed in the presence
of rotenone (Complex I inhibitor) or Complex II driven oxygen
consumption (succinate as substrate). We observed an incuba-
tion time-dependent effect of calcium on the mitochondria in
State III, State IV, and State V respiration. Interestingly, we again
did not observe changes in succinate-driven oxygen consumption
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FIGURE 1 | Ultra-structure of mitochondria is maintained after
percoll-purification. Percoll-purified mitochondria were analyzed for purity
and ultra-structure using electron microscopy (EM). The top panel (A)
displayed freshly isolated mitochondrial photograph (Scale: 2 cm = 2μm).
The bottom panels (B) and (C) displayed intact outer and inner
mitochondrial membranes along with maintained cristae (Scale: 1 cm =
0.1μm).
FIGURE 2 | Outer and inner mitochondrial membrane marker protein
levels are enriched with percoll-purification. Representative Western
blots show mitochondrial markers in the various fractions collected
during the isolation and purification procedure. The brain homogenate,
synaptosomal, and crude mitochondrial pellets (before and after nitrogen
bombing) fractions were collected for western blot analysis. The
percoll-purified mitochondrial fractions demonstrate an enrichment of
VDAC (outer membrane marker) and COX (inner membrane marker)
protein levels compared to the brain homogenate and the crude
mitochondrial fractions.
FIGURE 3 | Calcium inhibits mitochondrial respiration in a
dose-dependent manner. Representative traces show mitochondrial
oxygen consumption with and without calcium. Mitochondrial respiration
was carried out at 37◦C by incubating mitochondria in respiration buffer and
oxygen consumption of mitochondria was measured in response to
addition of various substrates and inhibitors. Baseline respiration was
termed as State I containing 125mM KCl respiration buffer and
mitochondria (25μg). State II was initiated by addition of 5mM pyruvate
and 2.5mM malate as substrates for Complex I of the ETC. Calcium
concentrations (0–1000 nmol/mg mitochondrial protein) were added to the
mitochondria at 1min followed by induction of State III respiration which
was initiated by activation of ATP Synthase (Complex V) via the addition of
ADP (150μM). State IV occurs when ATP Synthase is inhibited by addition
of oligomycin (2μM). FCCP (2μM) induces State V by uncoupling electron
transport from oxidative phosphorylation. Rotenone (1μM) was added
inhibit complex I activity followed by succinate (10mM) to measure
respiration through Complex II. All respiration measurements were made in
presence of 1mM L-Arg in KCl respiration buffer.
(Figure 6). Additionally, we measured mitochondrial Krebs cycle
enzyme PDHC and ETC Complex I enzyme activities to measure
direct effects of calcium on enzymes that contribute directly to the
production and utilization of NADH metabolites in mitochon-
dria. There were no changes observed in PDHC and Complex I
enzyme activities in the presence of calcium concentrations that
inhibited respiration in isolated mitochondria (Figure 7).
CALCIUM AND MITOCHONDRIAL H2O2 PRODUCTION
To determine if calcium could induce H2O2 production in
the isolated mitochondria, we used the indicator Amplex Red
to measure H2O2 production in four assay conditions [(1)
Basal (in KCl respiration buffer, no substrates or inhibitors
present), (2) under conditions of highest (oligomycin), and (3)
lowest (FCCP) membrane potentials () and also in pres-
ence of (4) Complex III inhibitor (antimycin A)]. We observed
a significant decrease in the fluorescence of mitochondria in
presence of calcium (100–20,000 nmol/mg mitochondrial pro-
tein) compared to those without calcium under conditions
that induced H2O2 production (Figure 8). In addition to this,
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FIGURE 4 | Calcium decreases mitochondrial respiratory control ratio
(RCR). Increasing concentrations of calcium were used at the doses
(0–1000 nmol/mg mitochondrial protein) as indicated and the RCR were
calculated as State III (presence of ADP) over State IV (absence of ADP and
presence of oligomycin). The mitochondrial RCR in the presence of calcium
was significantly lowered with increasing concentrations of calcium when
compared to the RCR of mitochondria with no calcium addition. Data
represent group means ± s.e.m.; n = 3 per group. One-Way ANOVA
followed by Fisher’s post-hoc test; ∗p < 0.05 compared to 0 nmol/mg
calcium.
FIGURE 5 | Calcium decreases mitochondrial bioenergetics in a
dose-dependent manner. Increasing doses of calcium were added to the
mitochondria after the addition of the complex I substrates pyruvate and
malate. An increase in the nmol of oxygen consumed upon addition of
calcium was observed, which reaches significance at 500 nmol/mg
mitochondrial protein and later. Similarly, with increasing calcium
concentrations, a trend in decreased bioenergetic response was observed
in State III (ADP) and State V (FCCP) respiration whereas State
IV(oligomycin) response remained unaltered. Calcium did not affect the
complex II (Succinate) driven oxygen consumption. Data represent group
means ± s.e.m.; n = 3 per group. One-Way ANOVA followed by Fisher’s
post-hoc test; ∗p < 0.05 compared to 0 nmol/mg calcium.
we measured total ROS/RNS measurements using DCF fluo-
rescence as an indicator (Figure 9) under similar experimen-
tal conditions. Under these conditions, we again observed a
significant decrease in the total ROS/RNS in presence of cal-
cium (500 nmol/mg mitochondrial protein) as compared control
group.
FIGURE 6 | Calcium decreases mitochondrial bioenergetics in a
time-dependent manner. Mitochondria (25μg) were co-incubated with
calcium after the addition of the complex I substrates (pyruvate and malate)
for increasing amounts of time (1–6min). An increase in the nmol of oxygen
consumed upon addition of calcium was observed, while State III (ADP)
driven respiration was inhibited with longer incubations with calcium
(25 nmols/mg mitochondrial protein = 2.5μM). When a higher
concentration of calcium was added (100 nmols/mg mitochondrial protein =
10μM), the inhibitory effect was more pronounced. However, as seen
previously in Figure 5, calcium did not affect the complex II (Succinate)
driven oxygen consumption. n = 2 per group.
FIGURE 7 | Calcium does not alter mitochondrial enzyme activities. For
measurement of PDHC and Complex I enzyme activities, mitochondrial
protein samples (10μg/100μl) were co-incubated with increasing calcium
concentrations (0–20,000 nmols/mg protein) range. For both PDHC and
Complex I assays, NAD+or NADH (Ex: 360 nm, Em: 460 nm) dependent
fluorescence change was recorded as an end-point measurement in
multiple wells across time. Both PDHC and Complex I enzyme activities
remained identical in calcium treated groups as compared to control group.
Data are expressed as percent change in fluorescence ± s.e.m.; n = 3 per
group. One-Way ANOVA followed by Fisher’s post-hoc test.
CALCIUM AND MITOCHONDRIAL MEMBRANE POTENTIAL ()
To determine if calcium altered mitochondrial , we used the
indicator TMRE, which is taken up by the mitochondria in a
membrane potential dependent manner. As expected, due to the
significant reductions in respiration, membrane potential was
reduced by the addition of Ca2+ (Figure 10). Of interest are
the observations that Ca2+ at 500 nmol/mg mitochondrial pro-
tein inhibits the mitochondrial depolarization that corresponds
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FIGURE 8 | Calcium decreases mitochondrial H2O2 production.
Mitochondrial hydrogen peroxide production was measured as various
doses of calcium (0–20,000 nmols/mg mitochondrial protein) were
co-incubated with energized mitochondria (10μg/100μl) in a 125mM KCl
respiration buffer (plus 5mM pyruvate and 2.5mM malate) for 0–10min
period at 30◦C under four different assay conditions (Basal, oligomycin,
antimycin A, FCCP). The 1μM Amplex Red (Ex: 485 nm, Em: 530 nm) and
0.25U HRP dependent fluorescence were recorded and differences in the
fluorescence units for 10min are expressed as arbitrary fluorescence units.
The H2O2 production remained unchanged with calcium treatment in a
basal respiratory condition where moderate mitochondrial membrane
potential () achieved. When H2O2 production with calcium
concentrations was measured at a maximal membrane potential () state
(when treated with oligomycin and antimycin A); it significantly reduced
with calcium treatment. Similarly, at minimal membrane potential ()
state (when treated with FCCP); the H2O2production remained significantly
lower or unchanged. Data represent group means ± s.e.m.; n = 3 per
group. One-Way ANOVA followed by Fisher’s post-hoc test; ∗p < 0.05
compared to 0 nmol/mg calcium.
to ADP addition. Ca2+ at 200 nmol/mg mitochondrial protein
also effects ADP phosphorylation evident by prolonged depolar-
ization following ADP addition.
CALCIUM AND MITOCHONDRIAL OXIDATIVE DAMAGE MARKERS
Lastly, to assess the total extent of mitochondrial oxidative dam-
age following Ca2+ exposure, we utilized slot-blots to measure
changes in markers of protein oxidation, lipid peroxidation and
protein nitration. We observed a trend for increases in the levels
of mitochondrial protein carbonyls. However, no differences were
observed with 4-hydroxynonenal (4-HNE) and 3-nitrotyrosine
(3-NT) oxidative damage markers when mitochondria were co-
incubated at the various concentrations of calcium (Figure 11).
DISCUSSION
The current study demonstrates that increasing calcium con-
centrations directly inhibit mitochondrial respiration in a dose
and time-dependent manner. Additionally, mitochondrial free
radical production was reduced at the levels of Ca2+ used in
the present study. Moreover, while we did observe changes in
mitochondrial levels of protein carbonyls (indicator of protein
oxidation); we did not observe any significant increase in the
levels of 3-Nitrotyrosine (3-NT; indicator of protein nitration)
and 4-Hydroxynonenal (4-HNE; indicator of lipid peroxidation)
oxidative damage markers in the presence of calcium. These
FIGURE 9 | Calcium decreases mitochondrial ROS/RNS levels.
Mitochondria (100μg) were added to a constantly stirred cuvette in a total
volume of 2ml of 125mM KCl buffer at 37◦C containing 1mM L-Arg, 10μM
H2DCF-DA (Ex: 485 nm, Em: 530 nm). Each run was performed with a
baseline reading of buffer. Mitochondria, calcium and the
substrates/inhibitors were added as indicated under identical mitochondrial
bioenergetics conditions utilized in Figure 3. The slope of DCF
fluorescence was quantified for the respective conditions including baseline
and expressed as arbitrary units. A significant decrease in DCF
fluorescence, as a measure of free radical generation, was observed in
mitochondria treated with calcium (500 nmol/mg mitochondrial protein)
compared control conditions. The decrease in DCF fluorescence was
calcium dose-dependent and was observed throughout with additions of
calcium, ADP, oligomycin, FCCP and rotenone but not with succinate
addition. Data represent group means ± SD; n = 3 per group. One-Way
ANOVA followed by Fisher’s post-hoc test; ∗p < 0.05 compared to
0nmol/mg calcium; @p < 0.05 compared to 200 nmol/mg calcium.
observations in isolated brain mitochondria indicate that mito-
chondrial respiration failure is an immediate primary event fol-
lowing calcium exposure whereas free radical production and
oxidative stress may become operative as secondary events after
energy failure. These results suggest a possible temporal “cause
vs. effect” relationship amongst mitochondrial mechanisms after
calcium exposure.
Even in the present study, under in vitro or ex vivo condi-
tions, it is apparent that mitochondrial bioenergetics and calcium
homeostasis operate in a very complex interaction. In vivo these
interactions are no doubt even more complex and involved other
cellular organelles including the endoplasmic reticulum (ER) and
cytosolic compartments. Therefore, there are multiple regulatory
components that can also influence calcium homeostasis and
mitochondrial respiration (Gnaiger, 2001; Gellerich et al., 2012,
2013; Llorente-Folch et al., 2013). It is also important to note the
findings of Gellerich and colleagues who have demonstrated elo-
quently the effects of low levels (<6 nmols Ca2+/mitochondrial
protein) Ca2+ on respiration in isolated brain mitochondria
which increases respiration (Gnaiger, 2001; Gellerich et al., 2012,
2013).
In the current study, we isolated ultrapurified cortical mito-
chondria (synaptic and nonsynaptic) using percoll discontinuous
gradient centrifugation. This means that the mitochondria iso-
lated for our study are from a heterogeneous sources of cell
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FIGURE 10 | Calcium decreases mitochondrial membrane potential
(). Mitochondria (100μg) were added to a constantly stirred cuvette in a
total volume of 2ml of 125mM KCl buffer at 37◦C containing 1mM L-Arg,
150 nM TMRE (Ex: 550 nm, Em: 575 nm). Each run was performed with a
baseline reading of buffer. Mitochondria, calcium and the
substrates/inhibitors were added as indicated. An increase in TMRE
fluorescence, as a measure of loss of mitochondrial membrane potential
(), was observed when mitochondria treated with calcium compared to
no calcium (slope of TMRE traces between 3 and 5min). Additionally, this
real-time loss of  was calcium dose-dependent; and was sustained in
the presence of ADP (slope of TMRE traces between 5 and 7min).
Additionally, a sharp bell shaped ADP response loss was evident with
increasing calcium dose due to reflective prior loss of  in presence of
calcium. n = 3 per group.
types, chiefly from neurons and glial cells. Additionally, mito-
chondria isolated from the brain are most often contaminated by
synaptosomes, formed by the pinched off pre- and post-synaptic
ends of neurons, that can alter and complicate the interpreta-
tion of results obtained from such mitochondrial preparations
(Anderson and Sims, 2000; Brown et al., 2006). Therefore, we
employed a method to release the synaptic mitochondria using
nitrogen disruption which increases the total yield of mitochon-
dria (Brown et al., 2004), while avoiding the adverse effects of
digitonin (Brustovetsky et al., 2002). We checked the purity of
these mitochondrial preparations by electron microscopy and
found them to have mostly mitochondria with preserved struc-
tures including intact cristae that lodge the ETC necessary for
oxidative phosphorylation (Figure 1). Moreover, mitochondrial
FIGURE 11 | Calcium does not alter protein and lipid oxidative stress
parameters. Using slot-blot assays, mitochondrial samples (200 ng/ml)
were treated with increasing calcium concentrations and markers for
protein oxidation (protein carbonyls), lipid peroxidation (4-HNE) and protein
nitration (3-NT) and blot intensities assessed and expressed as percent
increase compared to their levels in mitochondria without calcium. Protein
carbonyls trended toward an increase at lower concentrations of calcium
(100 and 200nmol/mg mitochondrial protein) compared to higher
concentrations (500 nmol/mg mitochondrial protein). However, these
changes were not statistically significant compared to control (no calcium).
No changes in the levels of 4-HNE or 3-nitrotyrosine (3-NT) were observed
with any of the calcium concentrations used. Data represent group means
± s.e.m.; n = 3 per group; One-Way ANOVA.
marker proteins such as VDAC for outer and COX for inner
mitochondrial membranes are enriched in the mitochondrial
fraction with the sequential purification steps (Figure 2) while
minimizing contamination. Furthermore, we used only fresh
mitochondria for the studies described in this paper, as frozen
mitochondria exhibit decreases in mitochondrial bioenergetics
(Nukala et al., 2006).
In our study, we added doses of Ca2+ (100–1000 nmol/mg
mitochondrial protein) in respiration buffer and examined its
and examined its effects on Complex I driven mitochondrial
respiration. We observed that calcium induced mitochondrial
dysfunction and the severity was dose-dependent (Figure 3), sim-
ilar to previous reports (Brustovetsky et al., 2003; Zhou et al.,
2005). Of interest is the fact that mitochondria subjected to den-
sity gradient centrifugation are more sensitive to Ca2+ effects
than unpurified CNS mitochondria (Brustovetsky and Dubinsky,
2000). We observed significant decreases in RCR (Figure 4), as
well as decreases in individual states, most noticeably in State III
(coupled respiration in presence of ADP) and to a lesser extent
in State V (maximal respiration in presence of FCCP) as seen in
Figure 5.
Though the oxygen consumption increased initially upon
addition of calcium and returned to State II respiration rates
(Figure 5), the later response to ADP was markedly affected, and
this could be due to the transient depolarizing effect experienced
with calcium onmembrane potential. In one study, mitochondria
exposed to a low Ca2+ concentration (4μM) resulted in a VDAC-
mediated reversible cytochrome c release, whereas at a higher
Ca2+ concentration (100μM), there was mitochondrial inhibi-
tion due tomPT induced irreversible cytochrome c release (Schild
et al., 2001). However, in the current study, no changes could be
observed in Complex II (succinate as the substrate) driven oxy-
gen consumption indicating that the calcium may target NADH
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dependent inhibition of mitochondrial respiration through inhi-
bition of Complex I or upstream enzymes that produce NADH
in the Krebs cycle. Dubinsky’s group, upon addition of calcium,
has shown that cytochrome c released was accompanied by mPT
and rupture of outer mitochondrial membrane. However, the
decline in mitochondrial respiration was attributed to inhibition
of Complex I rather than loss of cytochrome c (Brustovetsky et al.,
2002). Further, the inhibition of mitochondrial respiration was
exacerbated with longer exposures to calcium (Figure 6), consis-
tent with a previous study (Territo et al., 2000). In the present
study, no indication of mPT activation is apparent given the lack
of changes observed in state IV or complex II-driven respira-
tion. This suggests that deleterious effects of calcium are induced
immediately and sustained over a prolonged period of time that
may activate other secondary regulatory pathways after calcium
exposure.
To further probe the mechanism for this Complex I driven
impairment in respiration, we directly measured enzyme activi-
ties of twoNADHdependent enzymes, the Krebs cycle gate keeper
enzyme PDHC and ETC gate keeper Complex I in presence of
increasing calcium concentrations. We expected to see decreased
enzyme activities since they regulate NADH production and
utilization during mitochondrial respiration. Conversely, our
data in Figure 7 indicates that both the PDHC and Complex
I activities in presence of increasing calcium concentrations
were not altered significantly and remained identical to con-
trol group values. This could be due to the fact that calcium
may not inhibit those enzyme complexes directly. Alternatively,
decreased activities of brain mitochondrial PDHC and Complex
I reported by others in in vivo experiments in various neuro-
logical conditions may be due to oxidation of these enzymes
(Sorbi et al., 1983; Schapira et al., 1989; Keeney et al., 2006;
Gash et al., 2008; Andreazza et al., 2010). Furthermore, the
doses used in these studies may not reflect the actual concen-
trations that these enzymes are exposed to in respiring mito-
chondria given the electrogenic nature of mitochondrial Ca2+
cycling.
Mitochondria are major sources of free radicals inside the
cell due to leakage of electrons from ETC (Turrens, 2003), and
calcium is shown to influence ROS/RNS generation in mitochon-
dria by processes that are not completely understood (Camello-
Almaraz et al., 2006). This is evident by the divergent reports on
calcium increasing (Brustovetsky et al., 2003; Sousa et al., 2003;
Hansson et al., 2008), decreasing (Starkov et al., 2002; Starkov
and Fiskum, 2003; Gyulkhandanyan and Pennefather, 2004), or
causing no changes (Votyakova and Reynolds, 2001, 2005; Tretter
and Adam-Vizi, 2007) in the ROS/RNS levels of brain mito-
chondria. In general, processes of free radical formation, with
respect to mitochondrial membrane potential () dependence,
are not well defined or understood. Conclusively, succinate usu-
ally in presence of ETC inhibitors tends to produce higher levels of
ROS/RNS with calcium compared to pyruvate/malate/glutamate
as substrates. Hence, it was of interest in the present study to
assess calcium induced H2O2 and total ROS/RNS generation in
presence of respiratory substrates and inhibitors that regulate
mitochondrial . We used pyruvate and malate substrates for
measurement of complex I driven and NADH dependent free
radical productions when incubated in different calcium con-
centrations with isolated mitochondria. Also, we have included
known regulators such as oligomycin, antimycin A and FCCP
to understand the influence of calcium on  dependent H2O2
production.
Our current data demonstrated a significant decrease in -
dependent H2O2 production in the presence of calcium (in
presence of substrates pyruvate-malate with either oligomycin,
antimycin A, and FCCP). Additionally, no significant differences
were observed in H2O2 level in basal respiratory conditions when
no inhibitor and substrate were added (Figure 8). In another
experimental protocol, we observed significant decreases in total
ROS/RNS levels with calcium (500 nmol/mg mitochondrial pro-
tein) using an alternative free radical indicator, DCF (Figure 9).
This was accompanied by a partial loss of membrane potential
(Figure 10) as would be expected by the consumption of 
for mitochondrial uptake of calcium and subsequent inhibition
of mitochondrial respiration, supporting our data and previous
reports (Vergun and Reynolds, 2005).
Our lab has previously shown that non-synaptic mitochon-
dria are able to buffer more calcium than synaptic mitochondria
before losing the  and undergoing swelling; but they do
not exhibit differences in ROS/RNS levels (Brown et al., 2006;
Naga et al., 2007). Those non-synaptic and synaptic mitochondria
were able to sequester calcium concentrations i.e., 2500 nmols/mg
mitochondrial protein (250μM) and 1000 nmols/mg mitochon-
drial protein (100μM) respectively, which is higher than the
range used in the current set experiments (Figures 8, 9). One
important difference here is the use of total mitochondria and the
absence of ADP before the calcium challenge. It is known that
the presence of ADP reduces mitochondrial membrane potential
() and therefore the amount of calcium sequestered before
mPT formation (Andreyev et al., 1998). Another similar report
has also demonstrated that until mPT occurs ROS is not released
(Hansson et al., 2008), which was the reason we increased our
calcium concentration range up to 20000 nmol/mg mitochon-
drial protein for this set of experiment (Figure 8). Under 
influenced experimental conditions, the H2O2 levels remained
significantly lower as compared to control groups when treated
across the entire range of calcium concentrations. In this exper-
imental design, we added calcium concentrations (10–2000μM)
that cover the entire effective range that may or may not directly
induce mPT (Figure 8). The results from our experiments indi-
cate that inhibition of mitochondrial respiration via Ca2+ uptake
inhibits mitochondrial ROS production by limiting the influx of
substrates into the ETC which limits -dependent ROS pro-
duction. Additionally, when assaying these experiments, it should
also be kept in mind that Amplex Red and dichlorofluorescein
(DCF) which measures a range of total ROS/RNS including H2O2
and ONOO− are very susceptible to photo auto-oxidation and
proper controls must be used for samples including darkened
conditions, which we employed to obtain, are necessary to obtain
reliable results (Possel et al., 1997; Ischiropoulos et al., 1999; Radi
et al., 2001; Thomas et al., 2002).
Next we tested if the changes in H2O2 and total ROS/RNS lev-
els observed with calcium translated into changes in markers of
oxidative damage in the mitochondria (Figure 11). We measured
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the levels of protein carbonyls (an indicator of protein oxidation),
4-hydroxynonenal (4-HNE; indicator of lipid peroxidation). We
observed differences in protein carbonyls and 4-HNE at lower
concentrations of calcium indicating a trend toward an increase in
oxidative damage but significance was not achieved in the present
studies. Moreover, a wide variety of nitrated proteins have been
found in the mitochondria indicating involvement of peroxyni-
trite (Riobo et al., 2001; Elfering et al., 2004) and therefore we
measured the levels of 3-nitrotyrosine (3-NT; indicator for pro-
tein nitration). However, we did not observe any changes in levels
of 3-NT at any of the calcium doses tested even in the presence
of L- Arg (Figure 11). An absence of measurable or significant
changes in oxidative damage markers does not necessarily mean
a lack of H2O2 and total ROS/RNS involvement since we have
used isolated rat cortical mitochondria for in vitro experiments
in the presence of calcium. The methodology used measures the
extent of total oxidative damage and not the individual oxida-
tively modified proteins (Kohen and Nyska, 2002; Tarpey et al.,
2004). The short exposure time (less than 10min) of mitochon-
dria to calcium might be insufficient to elicit detectable changes
in total ROS/RNS levels and/or oxidative damagemarkers. In fact,
oxidative damage to certain key mitochondrial proteins, includ-
ing those involved in Krebs cycle or ETC has been observed.While
Complexes I and II of the ETC, creatine kinase are oxidatively
inactivated by peroxynitrite, ATP synthase, aconitase, VDAC, and
Mn-SOD are inactivated by nitration of tyrosine residues through
the peroxynitrite decomposition products (Radi et al., 2002). The
inactivation or inhibition of these specific proteins might be suf-
ficient to inhibit mitochondrial respiration (ex: ATP Synthase) or
amplify free radical generation (ex: Mn-SOD) and thereby con-
tribute to mitochondrial dysfunction ultimately resulting in cell
death.
Calcium induced mitochondrial dysfunction may be only one
of the many mechanisms responsible for the global cellular oxida-
tive stress and may require activation of the mPT (Hansson
et al., 2008). Another possible mechanism is the cytosolic calcium
induced activation of phospholipase A2 (PLA2) that mediates the
rapid release of arachidonic acid (AA) and lysophospholipids.
Some of the AA is converted to pro-inflammatory mediators such
as prostaglandins, leukotrienes, and thromboxanes, collectively
known as eicosanoids. AA cascade can lead to generation of free
radicals resulting in lipid peroxidation thereby altering plasma
membrane as well as mitochondrial membrane composition,
fluidity and permeability. The mitochondrial proteins can be oxi-
dized from such cytosolic sources of free radicals and nitrated by
cytosolic NOS mediated NO• and ONOO− generation. Further,
calcium activated cytosolic calpains can also degrade mitochon-
drial proteins thereby causing mitochondrial dysfunction. In
the current study, involvement of cytosolic mechanisms that
may influence mitochondrial structure and function were not
tested.
In summary, our experimental analysis of dose and time
dependent in vitro effects of calcium concentrations on mito-
chondrial bioenergetics and oxidative mechanisms may provide
valuable clarifications in isolated mitochondria. Further it may
be beneficial to design therapeutic strategies on the basis of
mitochondrial dysfunction parameters as they are prominent
in common pathologies following traumatic brain, spinal cord
injuries and other neurodegenerative conditions.
AUTHOR CONTRIBUTIONS
Drs. Pandya and Nukala designed and conducted experiments,
performed analysis and prepared manuscript. Dr. Sullivan con-
tributed and guided throughout the experimental planning and
manuscript preparation.
ACKNOWLEDGMENTS
The present study was funded by NIH grants NS 062993 and NS
069633 to Dr. Patrick G. Sullivan. We also would like to thank
Dr. L.M. Davis, Dr. N. P. Visavadiya, and Mrs. K. Siefert for their
excellent support in technical assistant and assay development.
REFERENCES
Anderson, M. F., and Sims, N. R. (2000). Improved recovery of highly
enriched mitochondrial fractions from small brain tissue samples.
Brain Res. Brain Res. Protoc. 5, 95–101. doi: 10.1016/S1385-299X(99)
00060-4
Andreazza, A. C., Andersen, M. L., Alvarenga, T. A., de-Oliveira, M. R., Armani,
F., Ruiz, F. S., et al. (2010). Impairment of the mitochondrial electron trans-
port chain due to sleep deprivation in mice. J. Psychiatr. Res. 44, 775–780. doi:
10.1016/j.jpsychires.2010.01.015
Andreyev, A. Y., Fahy, B., and Fiskum, G. (1998). Cytochrome c release
from brain mitochondria is independent of the mitochondrial perme-
ability transition. FEBS Lett. 439, 373–376. doi: 10.1016/S0014-5793(98)
01394-5
Berridge,M. J., Lipp, P., and Bootman,M. D. (2000). The versatility and universality
of calcium signalling. Nat. Rev. Mol. Cell Biol. 1, 11–21. doi: 10.1038/35036035
Brown, M. R., Sullivan, P. G., Dorenbos, K. A., Modafferi, E. A., Geddes, J. W., and
Steward, O. (2004). Nitrogen disruption of synaptoneurosomes: an alternative
method to isolate brain mitochondria. J. Neurosci. Methods 137, 299–303. doi:
10.1016/j.jneumeth.2004.02.028
Brown, M. R., Sullivan, P. G., and Geddes, J. W. (2006). Synaptic mitochondria
are more susceptible to ca2+ overload than non-synaptic mitochondria. J. Biol.
Chem. 281, 11658–11668. doi: 10.1074/jbc.M510303200
Brustovetsky, N., Brustovetsky, T., Jemmerson, R., and Dubinsky, J. M. (2002).
Calcium-induced cytochrome c release from cns mitochondria is associ-
ated with the permeability transition and rupture of the outer membrane.
J. Neurochem. 80, 207–218. doi: 10.1046/j.0022-3042.2001.00671.x
Brustovetsky, N., Brustovetsky, T., Purl, K. J., Capano, M., Crompton, M., and
Dubinsky, J. M. (2003). Increased susceptibility of striatal mitochondria to
calcium-induced permeability transition. J. Neurosci. 23, 4858–4867.
Brustovetsky, N., and Dubinsky, J. M. (2000). Dual responses of cns mitochondria
to elevated calcium. J. Neurosci. 20, 103–113.
Camello-Almaraz, C., Gomez-Pinilla, P. J., Pozo, M. J., and Camello, P. J. (2006).
Mitochondrial reactive oxygen species and ca2+ signaling. Am. J. Physiol. Cell
Physiol. 291, C1082–C1088. doi: 10.1152/ajpcell.00217.2006
Carafoli, E., Santella, L., Branca, D., and Brini, M. (2001). Generation, control, and
processing of cellular calcium signals. Crit. Rev. Biochem. Mol. Biol. 36, 107–260.
doi: 10.1080/20014091074183
Chalmers, S., and Nicholls, D. G. (2003). The relationship between free and total
calcium concentrations in the matrix of liver and brain mitochondria. J. Biol.
Chem. 278, 19062–19070. doi: 10.1074/jbc.M212661200
Chen, Q., Vazquez, E. J., Moghaddas, S., Hoppel, C. L., and Lesnefsky, E. J. (2003).
Production of reactive oxygen species by mitochondria: central role of complex
iii. J. Biol. Chem. 278, 36027–36031. doi: 10.1074/jbc.M304854200
Denton, R. M., Rutter, G. A., Midgley, P. J., and McCormack, J. G. (1988). Effects
of ca2+ on the activities of the calcium-sensitive dehydrogenases within the
mitochondria of mammalian tissues. J. Cardiovasc. Pharmacol. 12(Suppl. 5),
S69–S72.
Duchen, M. R. (2000). Mitochondria and ca(2+)in cell physiology and pathophys-
iology. Cell Calcium 28, 339–348. doi: 10.1054/ceca.2000.0170
Frontiers in Neuroenergetics www.frontiersin.org December 2013 | Volume 5 | Article 10 | 10
Pandya et al. Calcium impaired brain mitochondrial bioenergetics
Elfering, S. L., Haynes, V. L., Traaseth, N. J., Ettl, A., and Giulivi, C. (2004). Aspects,
mechanism, and biological relevance of mitochondrial protein nitration
sustained by mitochondrial nitric oxide synthase. Am. J. Physiol. Heart Circ.
Physiol. 286, H22–H29. doi: 10.1152/ajpheart.00766.2003
Floyd, R. A., and Hensley, K. (2002). Oxidative stress in brain aging: implications
for therapeutics of neurodegenerative diseases. Neurobiol. Aging 23, 795–807.
doi: 10.1016/S0197-4580(02)00019-2
Gash, D. M., Rutland, K., Hudson, N. L., Sullivan, P. G., Bing, G., Cass, W. A.,
et al. (2008). Trichloroethylene: parkinsonism and complex 1 mitochondrial
neurotoxicity. Ann. Neurol. 63, 184–192. doi: 10.1002/ana.21288
Geddes, J. W., and Sullivan, P. G. (2009). Special issue: mitochondria and neurode-
generation. Exp. Neurol. 218, 169–170. doi: 10.1016/j.expneurol.2009.05.011
Gellerich, F. N., Gizatullina, Z., Gainutdinov, T., Muth, K., Seppet, E., Orynbayeva,
Z., et al. (2013). The control of brain mitochondrial energization by cytoso-
lic calcium: the mitochondrial gas pedal. IUBMB Life 65, 180–190. doi:
10.1002/iub.1131
Gellerich, F. N., Gizatullina, Z., Trumbekaite, S., Korzeniewski, B., Gaynutdinov, T.,
Seppet, E., et al. (2012). Cytosolic ca2+ regulates the energization of isolated
brain mitochondria by formation of pyruvate through the malate-aspartate
shuttle. Biochem. J. 443, 747–755. doi: 10.1042/BJ20110765
Gnaiger, E. (2001). Bioenergetics at low oxygen: dependence of respiration and
phosphorylation on oxygen and adenosine diphosphate supply. Respir. Physiol.
128, 277–297. doi: 10.1016/S0034-5687(01)00307-3
Gunter, T. E., Yule, D. I., Gunter, K. K., Eliseev, R. A., and Salter, J.
D. (2004). Calcium and mitochondria. FEBS Lett. 567, 96–102. doi:
10.1016/j.febslet.2004.03.071
Gyulkhandanyan, A. V., and Pennefather, P. S. (2004). Shift in the localization of
sites of hydrogen peroxide production in brain mitochondria by mitochondrial
stress. J. Neurochem. 90, 405–421. doi: 10.1111/j.1471-4159.2004.02489.x
Hansson, M. J., Mansson, R., Morota, S., Uchino, H., Kallur, T., Sumi, T., et al.
(2008). Calcium-induced generation of reactive oxygen species in brain mito-
chondria is mediated by permeability transition. Free Radic. Biol. Med. 45,
284–294. doi: 10.1016/j.freeradbiomed.2008.04.021
Ischiropoulos, H., Gow, A., Thom, S. R., Kooy, N. W., Royall, J. A., and
Crow, J. P. (1999). Detection of reactive nitrogen species using 2,7-
dichlorodihydrofluorescein and dihydrorhodamine 123. Meth. Enzymol. 301,
367–373. doi: 10.1016/S0076-6879(99)01100-3
Jemmerson, R., Dubinsky, J. M., and Brustovetsky, N. (2005). Cytochrome c
release from cns mitochondria and potential for clinical intervention in
apoptosis-mediated cns diseases. Antioxid. Redox Signal. 7, 1158–1172. doi:
10.1089/ars.2005.7.1158
Keeney, P. M., Xie, J., Capaldi, R. A., and Bennett, J. P. Jr. (2006). Parkinson’s
disease brain mitochondrial complex i has oxidatively damaged subunits and
is functionally impaired and misassembled. J. Neurosci. 26, 5256–5264. doi:
10.1523/JNEUROSCI.0984-06.2006
Kohen, R., and Nyska, A. (2002). Oxidation of biological systems: oxidative stress
phenomena, antioxidants, redox reactions, and methods for their quantifica-
tion. Toxicol. Pathol. 30, 620–650. doi: 10.1080/01926230290166724
Kroemer, G., and Reed, J. C. (2000). Mitochondrial control of cell death. Nat. Med.
6, 513–519. doi: 10.1038/74994
Llorente-Folch, I., Rueda, C. B., Amigo, I., del Arco, A., Saheki, T., Pardo, B.,
et al. (2013). Calcium-regulation of mitochondrial respiration maintains atp
homeostasis and requires aralar/agc1-malate aspartate shuttle in intact cortical
neurons. J. Neurosci. 33, 13957–13971, 13971a. doi: 10.1523/JNEUROSCI.0929-
13.2013
Michelangeli, F., Ogunbayo, O. A., and Wootton, L. L. (2005). A plethora of
interacting organellar ca2+ stores. Curr. Opin. Cell Biol. 17, 135–140. doi:
10.1016/j.ceb.2005.01.005
Naga, K. K., Sullivan, P. G., and Geddes, J. W. (2007). High cyclophilin d con-
tent of synaptic mitochondria results in increased vulnerability to permeability
transition. J. Neurosci. 27, 7469–7475. doi: 10.1523/JNEUROSCI.0646-07.2007
Newmeyer, D. D., and Ferguson-Miller, S. (2003). Mitochondria: releasing power
for life and unleashing the machineries of death. Cell 112, 481–490. doi:
10.1016/S0092-8674(03)00116-8
Nicholls, D. G. (2005). Mitochondria and calcium signaling. Cell Calcium 38,
311–317. doi: 10.1016/j.ceca.2005.06.011
Nicholls, D. G. (2009). Mitochondrial calcium function and dysfunction in
the central nervous system. Biochim. Biophys. Acta 1787, 1416–1424. doi:
10.1016/j.bbabio.2009.03.010
Nicholls, D. G., and Chalmers, S. (2004). The integration of mitochondrial
calcium transport and storage. J. Bioenerg. Biomembr. 36, 277–281. doi:
10.1023/B:JOBB.0000041753.52832.f3
Nukala, V. N., Singh, I. N., Davis, L. M., and Sullivan, P. G. (2006).
Cryopreservation of brain mitochondria: a novel methodology for functional
studies. J. Neurosci. Methods 152, 48–54. doi: 10.1016/j.jneumeth.2005.08.017
Pandya, J. D., Pauly, J. R., Nukala, V. N., Sebastian, A. H., Day, K. M., Korde, A. S.,
et al. (2007). Post-injury administration of mitochondrial uncouplers increases
tissue sparing and improves behavioral outcome following traumatic brain
injury in rodents. J. Neurotrauma 24, 798–811. doi: 10.1089/neu.2006.3673
Pandya, J. D., Pauly, J. R., and Sullivan, P. G. (2009). The optimal dosage and
window of opportunity to maintain mitochondrial homeostasis following trau-
matic brain injury using the uncoupler fccp. Exp. Neurol. 218, 381–389. doi:
10.1016/j.expneurol.2009.05.023
Pandya, J. D., Sullivan, P. G., and Pettigrew, L. C. (2011). Focal cerebral ischemia
and mitochondrial dysfunction in the tnfalpha-transgenic rat. Brain Res. 1384,
151–160. doi: 10.1016/j.brainres.2011.01.102
Patel, S. P., Sullivan, P. G., Pandya, J. D., and Rabchevsky, A. G. (2009). Differential
effects of the mitochondrial uncoupling agent, 2,4-dinitrophenol, or the nitrox-
ide antioxidant, tempol, on synaptic or nonsynaptic mitochondria after spinal
cord injury. J. Neurosci. Res. 87, 130–140. doi: 10.1002/jnr.21814
Pedersen, P. L. (1999). Mitochondrial events in the life and death of ani-
mal cells: a brief overview. J. Bioenerg. Biomembr. 31, 291–304. doi:
10.1023/A:1005453700533
Pivovarova, N. B., and Andrews, S. B. (2010). Calcium-dependent mitochon-
drial function and dysfunction in neurons. FEBS J. 277, 3622–3636. doi:
10.1111/j.1742-4658.2010.07754.x
Possel, H., Noack, H., Augustin, W., Keilhoff, G., and Wolf, G. (1997). 2,7-
dihydrodichlorofluorescein diacetate as a fluorescent marker for peroxynitrite
formation. FEBS Lett. 416, 175–178. doi: 10.1016/S0014-5793(97)01197-6
Radi, R., Cassina, A., Hodara, R., Quijano, C., and Castro, L. (2002). Peroxynitrite
reactions and formation in mitochondria. Free Radic. Biol. Med. 33, 1451–1464.
doi: 10.1016/S0891-5849(02)01111-5
Radi, R., Peluffo, G., Alvarez, M. N., Naviliat, M., and Cayota, A. (2001).
Unraveling peroxynitrite formation in biological systems. Free Radic. Biol. Med.
30, 463–488. doi: 10.1016/S0891-5849(00)00373-7
Riobo, N. A., Clementi, E., Melani, M., Boveris, A., Cadenas, E., Moncada, S., et al.
(2001). Nitric oxide inhibits mitochondrial nadh: ubiquinone reductase activity
through peroxynitrite formation. Biochem. J. 359, 139–145. doi: 10.1042/0264-
6021:3590139
Schapira, A. H., Cooper, J. M., Dexter, D., Jenner, P., Clark, J. B., and Marsden, C.
D. (1989). Mitochondrial complex i deficiency in parkinson’s disease. Lancet 1,
1269. doi: 10.1016/S0140-6736(89)92366-0
Schild, L., Keilhoff, G., Augustin, W., Reiser, G., and Striggow, F. (2001). Distinct
ca2+ thresholds determine cytochrome c release or permeability transition
pore opening in brain mitochondria. FASEB J. 15, 565–567. doi: 10.1096/fj.00-
0551fje
Smaili, S. S., Hsu, Y. T., Carvalho, A. C., Rosenstock, T. R., Sharpe, J. C., and Youle,
R. J. (2003). Mitochondria, calcium and pro-apoptotic proteins as mediators in
cell death signaling. Braz. J. Med. Biol. Res. 36, 183–190. doi: 10.1590/S0100-
879X2003000200004
Sorbi, S., Bird, E. D., and Blass, J. P. (1983). Decreased pyruvate dehydrogenase
complex activity in huntington and alzheimer brain. Ann. Neurol. 13, 72–78.
doi: 10.1002/ana.410130116
Sousa, S. C., Maciel, E. N., Vercesi, A. E., and Castilho, R. F. (2003). Ca2+-
induced oxidative stress in brain mitochondria treated with the respira-
tory chain inhibitor rotenone. FEBS Lett. 543, 179–183. doi: 10.1016/S0014-
5793(03)00421-6
Sriram, K., Shankar, S. K., Boyd, M. R., and Ravindranath, V. (1998).
Thiol oxidation and loss of mitochondrial complex i precede exci-
tatory amino acid-mediated neurodegeneration. J. Neurosci. 18,
10287–10296.
Starkov, A. A., and Fiskum, G. (2003). Regulation of brain mitochondrial h2o2
production by membrane potential and nad(p)h redox state. J. Neurochem. 86,
1101–1107. doi: 10.1046/j.1471-4159.2003.01908.x
Starkov, A. A., Fiskum, G., Chinopoulos, C., Lorenzo, B. J., Browne, S. E.,
Patel, M. S., et al. (2004). Mitochondrial alpha-ketoglutarate dehydrogenase
complex generates reactive oxygen species. J. Neurosci. 24, 7779–7788. doi:
10.1523/JNEUROSCI.1899-04.2004
Frontiers in Neuroenergetics www.frontiersin.org December 2013 | Volume 5 | Article 10 | 11
Pandya et al. Calcium impaired brain mitochondrial bioenergetics
Starkov, A. A., Polster, B. M., and Fiskum, G. (2002). Regulation of hydrogen per-
oxide production by brain mitochondria by calcium and bax. J. Neurochem. 83,
220–228. doi: 10.1046/j.1471-4159.2002.01153.x
Sullivan, P. G., Rabchevsky, A. G., Keller, J. N., Lovell, M., Sodhi, A., Hart, R.
P., et al. (2004). Intrinsic differences in brain and spinal cord mitochondria:
implication for therapeutic interventions. J. Comp. Neurol. 474, 524–534. doi:
10.1002/cne.20130
Sullivan, P. G., Rabchevsky, A. G., Waldmeier, P. C., and Springer, J. E. (2005).
Mitochondrial permeability transition in cns trauma: cause or effect of neuronal
cell death? J. Neurosci. Res. 79, 231–239. doi: 10.1002/jnr.20292
Tarpey, M. M., Wink, D. A., and Grisham, M. B. (2004). Methods for detection
of reactive metabolites of oxygen and nitrogen: In vitro and in vivo consid-
erations. Am. J. Physiol. Regul. Integr. Comp. Physiol. 286, R431–R444. doi:
10.1152/ajpregu.00361.2003
Territo, P. R., Mootha, V. K., French, S. A., and Balaban, R. S. (2000). Ca(2+) acti-
vation of heart mitochondrial oxidative phosphorylation: role of the f(0)/f(1)-
atpase. Am. J. Physiol. Cell Physiol. 278, C423–C435.
Thomas, D. D., Miranda, K. M., Espey, M. G., Citrin, D., Jourd’heuil D, Paolocci,
N., et al. (2002). Guide for the use of nitric oxide (no) donors as probes of the
chemistry of no and related redox species in biological systems. Meth. Enzymol.
359, 84–105. doi: 10.1016/S0076-6879(02)59174-6
Tretter, L., and Adam-Vizi, V. (2007). Moderate dependence of ros formation on
deltapsim in isolated brain mitochondria supported by nadh-linked substrates.
Neurochem. Res. 32, 569–575. doi: 10.1007/s11064-006-9130-y
Turrens, J. F. (2003). Mitochondrial formation of reactive oxygen species. J. Physiol.
552, 335–344. doi: 10.1113/jphysiol.2003.049478
Vergun, O., and Reynolds, I. J. (2005). Distinct characteristics of ca(2+)-induced
depolarization of isolated brain and liver mitochondria. Biochim. Biophys. Acta
1709, 127–137. doi: 10.1016/j.bbabio.2005.07.006
Visavadiya, N. P., McEwen, M. L., Pandya, J. D., Sullivan, P. G., Gwag, B. J.,
and Springer, J. E. (2013). Antioxidant properties of neu2000 on mitochon-
drial free radicals and oxidative damage. Toxicol. In Vitro 27, 788–797. doi:
10.1016/j.tiv.2012.12.011
Votyakova, T. V., and Reynolds, I. J. (2001). Deltapsi(m)-dependent and -
independent production of reactive oxygen species by rat brain mitochondria.
J. Neurochem. 79, 266–277. doi: 10.1046/j.1471-4159.2001.00548.x
Votyakova, T. V., and Reynolds, I. J. (2005). Ca2+-induced permeabilization pro-
motes free radical release from rat brain mitochondria with partially inhibited
complex i. J. Neurochem. 93, 526–537. doi: 10.1111/j.1471-4159.2005.03042.x
Wallace, D. C. (2005). A mitochondrial paradigm of metabolic and degenerative
diseases, aging, and cancer: a dawn for evolutionarymedicine.Annu. Rev. Genet.
39, 359–407. doi: 10.1146/annurev.genet.39.110304.095751
Wan, B., LaNoue, K. F., Cheung, J. Y., and Scaduto, R. C. Jr. (1989). Regulation of
citric acid cycle by calcium. J. Biol. Chem. 264, 13430–13439.
Zhou, P., Qian, L., Zhou, T., and Iadecola, C. (2005). Mitochondria are involved in
the neurogenic neuroprotection conferred by stimulation of cerebellar fastigial
nucleus. J. Neurochem. 95, 221–229. doi: 10.1111/j.1471-4159.2005.03358.x
Conflict of Interest Statement: The authors declare that the research was con-
ducted in the absence of any commercial or financial relationships that could be
construed as a potential conflict of interest.
Received: 09 October 2013; paper pending published: 07 November 2013; accepted: 26
November 2013; published online: 18 December 2013.
Citation: Pandya JD, Nukala VN and Sullivan PG (2013) Concentration dependent
effect of calcium on brain mitochondrial bioenergetics and oxidative stress parameters.
Front. Neuroenergetics 5:10. doi: 10.3389/fnene.2013.00010
This article was submitted to the journal Frontiers in Neuroenergetics.
Copyright © 2013 Pandya, Nukala and Sullivan. This is an open-access article dis-
tributed under the terms of the Creative Commons Attribution License (CC BY). The
use, distribution or reproduction in other forums is permitted, provided the original
author(s) or licensor are credited and that the original publication in this jour-
nal is cited, in accordance with accepted academic practice. No use, distribution or
reproduction is permitted which does not comply with these terms.
Frontiers in Neuroenergetics www.frontiersin.org December 2013 | Volume 5 | Article 10 | 12
